Cyclic Materials, a company specialising in the recycling of rare earth elements (REEs), has announced an investment of more ...

From 10 to 13 February 2026, Biocyclic Vegan International with its German association Förderkreis Biozyklisch-Veganer Anbau ...

For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation ...

A trial involving more than 400 people reveals that intense breathing and cold showers improve energy and mental clarity in just 29 days.

Firm will use the funding to complete its FAA certification and install SkyOS system on new airframes.

FNF looks 30% undervalued with a 4% yield, low forward P/E, and counter-cyclical F&G cash flow. Read more macro analysis here.

Pittcon 2026 in San Antonio highlights Texas's advancements in electrochemistry, bridging fundamental research and practical ...

ABANZA, a company focused on next-generation soft-tissue repair solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for QuadLock(TM), its new ...

Researchers from Kumamoto University have developed a new peptide-based technology that enables insulin—normally injected—to be taken orally while still powerfully lowering blood sugar. Their ...

A new three-way bond-breaking and making mechanism makes the synthesis of five-membered rings easier than before.

For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation in the digestive tract and the absence of a dedicated intestinal transport ...

Medical technology company Abanza has received FDA 510(k) clearance for QuadLock, a fixation system for ACL reconstruction.  The system can be used across several graft configurations that are ...